KZIA Kazia Therapeutics Ltd

STAMFORD, Conn. and SYDNEY, Australia, Oct. 30 /PRNewswire-FirstCall/ -- Novogen Limited (NASDAQ:NVGN)(ASX:NRT) will present at the Rodman & Renshaw 8th Annual Healthcare Conference at the New York Palace Hotel on Tuesday 7 November, 2006 at 4:35 pm. About Novogen Novogen is an Australian based biotechnology company in the business of research and development of drugs derived from its phenolic technology platform. The Company manages its research and development programs utilizing the expertise and clinical research capabilities of universities and hospitals in Australia, USA and Europe. Novogen's drug program is researching and developing compounds for the treatment of cancer, cardiovascular disease and anti-inflammatory disease. http://www.novogen.com/ DATASOURCE: Novogen Limited CONTACT: Christopher Naughton, Managing Director, of Novogen Limited, + 61 (02) 9878 0088; or David Sheon, +1-202-518-6321, for Novogen Limited Web site: http://www.novogen.com/

Copyright